These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1031 related items for PubMed ID: 15598474

  • 1. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
    Dorsey CM, Lee KA, Scharf MB.
    Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
    Roth T, Soubrane C, Titeux L, Walsh JK, Zoladult Study Group.
    Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
    [Abstract] [Full Text] [Related]

  • 3. Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial.
    Soares CN, Joffe H, Rubens R, Caron J, Roth T, Cohen L.
    Obstet Gynecol; 2006 Dec; 108(6):1402-10. PubMed ID: 17138773
    [Abstract] [Full Text] [Related]

  • 4. Eight weeks of non-nightly use of zolpidem for primary insomnia.
    Walsh JK, Roth T, Randazzo A, Erman M, Jamieson A, Scharf M, Schweitzer PK, Ware JC.
    Sleep; 2000 Dec 15; 23(8):1087-96. PubMed ID: 11145323
    [Abstract] [Full Text] [Related]

  • 5. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB, Roth T, Vogel GW, Walsh JK.
    J Clin Psychiatry; 1994 May 15; 55(5):192-9. PubMed ID: 8071269
    [Abstract] [Full Text] [Related]

  • 6. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
    Roger M, Attali P, Coquelin JP.
    Clin Ther; 1993 May 15; 15(1):127-36. PubMed ID: 8458042
    [Abstract] [Full Text] [Related]

  • 7. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M, Asnis GM, Shrivastava RK, Lydiard B, Bastani B, Sheehan DV, Roth T.
    J Clin Psychiatry; 2011 Jul 15; 72(7):914-28. PubMed ID: 21208597
    [Abstract] [Full Text] [Related]

  • 8. Severe hot flashes are associated with chronic insomnia.
    Ohayon MM.
    Arch Intern Med; 2006 Jun 26; 166(12):1262-8. PubMed ID: 16801508
    [Abstract] [Full Text] [Related]

  • 9. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
    Ozone M, Yagi T, Itoh H, Tamura Y, Inoue Y, Uchimura N, Sasaki M, Shimizu T, Terzano MG, Parrino L.
    Pharmacopsychiatry; 2008 May 26; 41(3):106-14. PubMed ID: 18484552
    [Abstract] [Full Text] [Related]

  • 10. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
    Hajak G, Hedner J, Eglin M, Loft H, Stórustovu SI, Lütolf S, Lundahl J, Gaboxadol Study 99775 Group.
    Sleep Med; 2009 Aug 26; 10(7):705-12. PubMed ID: 19346160
    [Abstract] [Full Text] [Related]

  • 11. Eszopiclone improves insomnia and depressive and anxious symptoms in perimenopausal and postmenopausal women with hot flashes: a randomized, double-blinded, placebo-controlled crossover trial.
    Joffe H, Petrillo L, Viguera A, Koukopoulos A, Silver-Heilman K, Farrell A, Yu G, Silver M, Cohen LS.
    Am J Obstet Gynecol; 2010 Feb 26; 202(2):171.e1-171.e11. PubMed ID: 20035910
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
    Walsh JK, Soubrane C, Roth T.
    Am J Geriatr Psychiatry; 2008 Jan 26; 16(1):44-57. PubMed ID: 18165461
    [Abstract] [Full Text] [Related]

  • 13. Self-reported efficacy and tolerability of ramelteon 8 mg in older adults experiencing severe sleep-onset difficulty.
    Mini LJ, Wang-Weigand S, Zhang J.
    Am J Geriatr Pharmacother; 2007 Sep 26; 5(3):177-84. PubMed ID: 17996657
    [Abstract] [Full Text] [Related]

  • 14. Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia.
    Monti JM, Alvariño F, Monti D.
    Sleep; 2000 Dec 15; 23(8):1075-84. PubMed ID: 11145322
    [Abstract] [Full Text] [Related]

  • 15. Effect of zolpidem on sleep architecture and its next-morning residual effect in insomniac patients: a randomized crossover comparative study with brotizolam.
    Uchimura N, Nakajima T, Hayash K, Nose I, Hashizume Y, Ohyama T, Habukawa M, Kotorii N, Kuwahara H, Maeda H.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan 15; 30(1):22-9. PubMed ID: 16048734
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of modified-release indiplon in elderly patients with chronic insomnia: results of a 2-week double-blind, placebo-controlled trial.
    Lydiard RB, Lankford DA, Seiden DJ, Landin R, Farber R, Walsh JK.
    J Clin Sleep Med; 2006 Jul 15; 2(3):309-15. PubMed ID: 17561543
    [Abstract] [Full Text] [Related]

  • 17. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T, White D, Schmidt-Nowara W, Wesnes KA, Niebler G, Arora S, Black J.
    Clin Ther; 2006 May 15; 28(5):689-706. PubMed ID: 16861091
    [Abstract] [Full Text] [Related]

  • 18. Controlled clinical trial of zolpidem for the treatment of insomnia associated with attention-deficit/ hyperactivity disorder in children 6 to 17 years of age.
    Blumer JL, Findling RL, Shih WJ, Soubrane C, Reed MD.
    Pediatrics; 2009 May 15; 123(5):e770-6. PubMed ID: 19403468
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and tolerability of indiplon in older adults with primary insomnia.
    Walsh JK, Moscovitch A, Burke J, Farber R, Roth T.
    Sleep Med; 2007 Nov 15; 8(7-8):753-9. PubMed ID: 17825616
    [Abstract] [Full Text] [Related]

  • 20. An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia.
    Roth T, Walsh JK, Krystal A, Wessel T, Roehrs TA.
    Sleep Med; 2005 Nov 15; 6(6):487-95. PubMed ID: 16230048
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 52.